GB9502858D0 - Novel use of matrix metalloproteinase inhibitors - Google Patents
Novel use of matrix metalloproteinase inhibitorsInfo
- Publication number
- GB9502858D0 GB9502858D0 GBGB9502858.5A GB9502858A GB9502858D0 GB 9502858 D0 GB9502858 D0 GB 9502858D0 GB 9502858 A GB9502858 A GB 9502858A GB 9502858 D0 GB9502858 D0 GB 9502858D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- matrix metalloproteinase
- metalloproteinase inhibitors
- novel use
- novel
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9502858.5A GB9502858D0 (en) | 1995-02-14 | 1995-02-14 | Novel use of matrix metalloproteinase inhibitors |
| EP96902330A EP0809491A1 (en) | 1995-02-14 | 1996-02-13 | Use of matrix metalloproteinase inhibitors for the treatment of diseases mediated by tnf-alpha |
| PCT/GB1996/000280 WO1996025156A1 (en) | 1995-02-14 | 1996-02-13 | Use of matrix metalloproteinase inhibitors for the treatment of diseases mediated by tgf-alpha |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9502858.5A GB9502858D0 (en) | 1995-02-14 | 1995-02-14 | Novel use of matrix metalloproteinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9502858D0 true GB9502858D0 (en) | 1995-04-05 |
Family
ID=10769573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9502858.5A Pending GB9502858D0 (en) | 1995-02-14 | 1995-02-14 | Novel use of matrix metalloproteinase inhibitors |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0809491A1 (en) |
| GB (1) | GB9502858D0 (en) |
| WO (1) | WO1996025156A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998018754A1 (en) | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| US6281245B1 (en) | 1996-10-28 | 2001-08-28 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| EP0971895A1 (en) | 1997-03-28 | 2000-01-19 | AstraZeneca AB | Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| GB9708133D0 (en) * | 1997-04-22 | 1997-06-11 | British Biotech Pharm | Novel use of matrix metalloproteinase inhibitors |
| WO2003079972A2 (en) | 2002-02-22 | 2003-10-02 | New River Parmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| AR036053A1 (en) | 2001-06-15 | 2004-08-04 | Versicor Inc | N-FORMIL-HYDROXYLAMINE COMPOUNDS, A PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS |
| CN1512991A (en) | 2001-06-15 | 2004-07-14 | ά����ҩ�﹫˾ | Pyrrolidine bicyclic compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| EP0634998B1 (en) * | 1992-04-07 | 1997-03-19 | British Biotech Pharmaceuticals Limited | Hydroxamic acid based collagenase and cytokine inhibitors |
| GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| NZ262447A (en) * | 1993-03-16 | 1996-07-26 | British Biotech Pharm | Hydroxamic acid derivatives and their use as pharmaceutical agents |
-
1995
- 1995-02-14 GB GBGB9502858.5A patent/GB9502858D0/en active Pending
-
1996
- 1996-02-13 WO PCT/GB1996/000280 patent/WO1996025156A1/en not_active Application Discontinuation
- 1996-02-13 EP EP96902330A patent/EP0809491A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996025156A1 (en) | 1996-08-22 |
| EP0809491A1 (en) | 1997-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL331254A1 (en) | Phosphonianic inhibitors of matrix metaloproteases | |
| PL323710A1 (en) | Reversible inhibitors of cysteinic protease | |
| HUP9902083A3 (en) | Sulfonamide inhibitors of matrix metalloproteinases | |
| PL327569A1 (en) | Promedications of thrombosin inhibitors | |
| ZA959948B (en) | Matrix metalloprotease inhibitors | |
| GB9405076D0 (en) | A medical use of matrix metalloproteinase inhibitors | |
| PL321759A1 (en) | Novel thrombosin inhibitors | |
| PL326508A1 (en) | Protease inhibitors | |
| HUP9903863A3 (en) | Metalloproteinase inhibitors | |
| PL331854A1 (en) | Phosphinamides as inhibitors of metaloprotease matrix | |
| FI980033A0 (en) | Inhibitors of cell attachment | |
| SI1445259T1 (en) | Use of crystal forms of 2-methyl-thieno-benzodiazepine | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| IL117638A0 (en) | Reversible protease inhibitors | |
| PL337725A1 (en) | Inhibitors of proteases | |
| PL330897A1 (en) | Inhibitors of matrix metaloproteinase | |
| EP0722436A4 (en) | Mercaptosulfide metalloproteinase inhibitors | |
| GB9502858D0 (en) | Novel use of matrix metalloproteinase inhibitors | |
| GB9708133D0 (en) | Novel use of matrix metalloproteinase inhibitors | |
| GB9627016D0 (en) | Novel use of matrix metalloproteinase inhibitors | |
| GB9700233D0 (en) | Use of glycosidase inhibitors | |
| AU7502696A (en) | Matrix metalloproteinase inhibitors and their therapeutic use | |
| SI0828726T1 (en) | Tricyclic inhibitors of matrix metalloproteinases | |
| ZA9610604B (en) | Matrix metalloprotease inhibitors | |
| SI0874836T1 (en) | Sulfonamide inhibitors of matrix metalloproteinases |